OVARIAN CANCER

Xiaoya 35-year-old three years ago has just done a mother, early last year because of improper contraception and pregnancy. Finish abortion, xiaoya did not feel that their physical Breckenridge. But this summer she saw his terrible physical changes: the original sleek hair limbs suddenly developed, and even the lips of sorts-a lot to live in.. "I do not know that abortion is not the reason?" Xiaoya hearts quietly committed abroad, and has since skirts and Farewell.
Suddenly developed sweat glands finally explained. It is the company's first comprehensive medical examination, an experienced doctor told xiaoya old, she won "
Polycystic ovarian cyst, "High blood levels of the male hormone is her hair suddenly developed reasons. Always consider themselves very healthy xiaoya disease struck suddenly feel the fear.

Tags: benign, blood, cancer, cause, cyst, cystic, cysts, early, eat, ert, estrogen, examination, gynecological, knowledge, malignant, mass, ovarian, ovary, physical, polycystic, rate, surface, surgery, symptoms, syndrome, time, treatment, tumor, tumors, usually, women, xiaoya

For what age women should be preventive ovariectomy, between different gynecological physician there is a considerable difference. Jacobs Oram and the Royal College of Obstetrics and Gynecology doctors on preventive attitude ovariectomized done a survey, the results showed that: only 2% to gynecologists for women aged 40 to 44 the ovary; 20% of doctors agreed with 45 to 49-year-old women's ovary; 51% think Resectability aged over 49-year-old women's ovary; 85% agree that postmenopausal women with ovarian. Alaska gynecologists, 35% agree with women aged 40 to 44 the ovary; 81% agree with women aged 45 to 49 the ovary; 95% agree with women over the age of 49, the ovary.
Some of the literature suggested that the age for women aged ≥ 40 ovariectomized preventive purposes. However, while some other articles that only deal with ≥ 45 years of age patients with preventive ovariectomy. It is clear that the majority of women with ovarian also not aware of estrogen replacement therapy (estrogen replacement therapy, ERT) the importance, from the reported in the literature it is not difficult to see that the compliance ERT not ideal, however, the role of estrogen loss is real. After ovariectomy, the ERT begin compliance was 31% to 89%; The long-term application, a decrease of 13% to 51%. Under existing ERT compliance of the relevant information can be estimated preventive ovariectomized will lead to the age of 45 or more young women to shorten life expectancy. For example, a 35-year-old women, in preventive ovary after, if they failed to ERT, then her life expectancy will decrease 1.4 years. Siddle, proved to hysterectomy for women, ovarian failure will be the age of natural menopause, as early as four years (45.4? ? .0 49.5-right? ? .04), And 34% of women in the two years after emerging ovarian failure and menopause symptoms .
Thus, clinicians must be aware of ovarian hysterectomy after reservation for women should be ahead of ERT treatment.

Tags: age, early, eat, ert, estrogen, gynecological, head, life, ovarian, ovary, patients, preventive, symptoms, therapy, treatment, women

Serous cystadenoma
Zhu serous tumor of the kidney from the body cavity epithelium, is the most common tumors of the ovary. According to national statistics, the total of 2007-09-07 16:00:00.1% of ovarian tumors common in women aged 30-40. The unilateral nature, but there are also many of the bilateral. Simple solution can be divided into gland capsule and two papillary serous cystadenoma.

Tags: abdominal, age, amenorrhea, annex, anti, benign, bleeding, blood, body, breast, cancer, carcinoma, cases, cause, cell, cells, children, clinical, cyst, cystic, cysts, diagnosis, early, eat, ert, estrogen, gene, group, groups, growth, incidence, increased, malignant, mass, metastasis, metastatic, oppression, ovarian, ovary, patients, pelvic, poor, prognosis, protein, quality, radiation, rate, resection, surface, surgery, surgical, survival, symptoms, time, treatment, tumor, tumors, usually, uterine, women

Epithelial ovarian cancer in the United States is a relatively rare in Gynecologic Oncology, 2004, there were approximately 25,580 cases of new onset patients, 16,090 cases patients died. The majority of patients with advanced cancer, treatment for surgical resection and postoperative to platinum-based chemotherapy. During the past 10 years, chemotherapy improved survival rates improve, and recurrent tumor treatment more effective. In addition, the genetic risk factors for making in-depth understanding of the prevention strategy to become individualized approach to bilateral tubal women - ovarian surgery. This report summarized the clinical characteristics of epithelial ovarian, after reports focus on the treatment of the latest developments.

Tags: age, brca1, breast, cancer, carcinoma, cases, cause, chemotherapy, clinical, diagnosis, drug, drugs, early, eat, ert, estrogen, examination, family, gene, group, groups, history, incidence, increased, life, malignant, mutation, ovarian, ovary, patients, pelvic, preventive, protein, rate, reduce, resection, risk, screening, second, study, surface, surgery, surgical, survival, syndrome, therapy, time, treatment, tumor, usually, women

Amenorrhea is common clinical symptoms, their causes are complex, the causes can be divided into the central nervous system and the hypothalamus, pituitary, ovary and uterus of amenorrhea, including congenital Gonadal Dysgenesis and autoimmune ovarian inflammation. As such closure gonadotropin levels often associated with higher estrogen levels decrease, it said hypergonadotropic amenorrhea, gonadotropin levels higher than normal cycle or reached menopause, clinical manifestations of primary or secondary amenorrhea.

Tags: age, amenorrhea, anti, blood, body, cause, clinical, diagnosis, eat, ert, estrogen, examination, gene, ovarian, ovary, patients, pelvic, poor, positive, rate, second, symptoms, time, treatment

One, paclitaxel and cisplatin in the treatment of advanced ovarian cancer care <BR> <BR> 1990s Taxol is more of the treatment of advanced ovarian cancer drug effective, and its unique mechanism is a new type of anti-tubulin role of antitumor drugs. Cisplatin for inorganic platinum metal complex, the cell cycle-specific drug, can inhibit DNA synthesis, combined with their synergies to enhance the effectiveness of [1]. In Division I from July 1996 to July 1998 to 15 cases of advanced ovarian cancer patients with Taxol and cisplatin in the treatment of satisfactory results.

One, information and Methods

Tags: administration, age, anti, blood, body, cancer, care, cases, cause, cell, cells, chemotherapy, cisplatin, clinical, confidence, days, diet, dose, drug, drugs, eat, ert, estrogen, family, fat, gene, group, growth, incidence, infusion, injection, intravenous, life, mass, metastasis, method, ovarian, paclitaxel, pain, patients, physical, poor, positive, psychological, quality, rate, reduce, response, skin, surface, surgery, survival, symptoms, taxol, therapy, time, toxicity, treatment, tumor, tumors, women

I. Overview

With the aging of the global trend of development, improve the economic status of women, more and more women start hormone replacement therapy (Hormone Replacement Therapy, HRT), to improve access to after menopause due to the decrease in the level of sex hormones related to various diseases. Clear evidence that: postmenopausal women with age, the incidence of coronary heart disease increased by about four times the fracture due to osteoporosis by 20%, died of complications due to pelvic fracture rate of 30%, after the 65-year-old Alzheimer's incidence rate increase every year <BR> and Application HRT can peer groups coronary heart disease risk 50% Alzheimer's risk reduced three times, especially worth mentioning is significantly reduced the incidence of rectal cancer. Long-term use of HRT cancer risk reduced year by year. HRT can also greatly improve the menopause, postmenopausal women with disease or ovarian surgery, radiotherapy in patients with a series of artificial menopause syndrome.

Tags: age, benign, blood, body, brca1, breast, cancer, carcinoma, care, cases, cause, cell, cells, clinical, cyst, cystic, diagnosis, diet, drug, early, eat, ert, estrogen, family, fat, gene, grams, group, groups, growth, gynecological, history, hrt, incidence, increased, injection, intravenous, life, lymph, malignant, metastasis, method, mutation, node, ovarian, patients, pelvic, positive, protein, quality, radiotherapy, rate, reduce, residual, risk, screening, second, study, surgery, surgical, survival, syndrome, therapy, time, treatment, tumor, tumors, usually, uterine, women

Mesenchymal cells of the ovary (Loydig cell tumor):

(1) of the cell door: This tumor is rare. As a <BR> ovarian portal that since the tumor cell door. More common in women after menopause, the main clinical manifestations of masculine symptoms, but sometimes there will be high performance estrogen, and with endometrial hyperplasia, endometrial cancer.

[Giant seizure] often unilateral, bilateral and occasionally simultaneously ovarian tumor. Tumor sizes. In ovarian portal, but the majority of ovarian tumors can be occupied. Tumor section for substantive, yellow or brownish yellow, with cystic degeneration and bleeding.

Tags: anti, bleeding, cancer, cell, cells, clinical, cyst, cystic, estrogen, gene, ovarian, ovary, symptoms, time, tumor, tumors, women

Ovarian cancer is common gynecologic cancer, female genital tumors about 1 / 3. Can occur at any age, and women with reproductive seen. The incidence of ovarian cancer is women's genital cancer Habitat third place, as early diagnosis difficult, often found at the already advanced, but the mortality rate for the first gynecologic malignancies.
[Diagnosis]

A Symptoms

(1) abdominal discomfort or medium sized benign tumor rapid growth often cause bloating and discomfort.

(2) abdominal mass benign swelling growth slow, difficult to be discovered, patients are often inadvertently touched. Malignant tumors grow fast, easily detected.

Tags: abdominal, age, anti, benign, bleeding, blood, cancer, carcinoma, cause, cell, cells, cyst, cystic, diagnosis, early, eat, ert, estrogen, examination, gene, growth, incidence, increased, lymph, malignant, mass, metastasis, metastatic, node, oppression, ovarian, ovary, pain, patients, pelvic, positive, rate, reduce, surface, symptoms, tumor, tumors, uterine, women

[Summary]

Ovarian cancer is a common cancer of female genital mutilation one of the incidence of cervical cancer and after cancer of the uterus, which ranked third. But ovarian cancer death, accounts of the first gynecologic tumors, right pose a serious threat to women's lives. Because ovarian embryonic development, organization anatomy and endocrine function more complicated, it may be suffering from benign tumors or malignant. Because of early ovarian cancer in asymptomatic, and the identification of its type benign and malignant very difficult, ovarian carcinoma laparotomy in ovarian tumor confined to only 30%, most have spread to the uterus, bilateral annex, the omentum and pelvic organs, both in the diagnosis of ovarian cancer and governance the treatment is a major problem indeed. Over the years experts on the pathological form of ovarian cancer, the development of clinical and treatment programs for many of accumulated a lot of experience, so far, statistics on domestic and foreign clinical data, the five-year survival rate of only 25% to 30%.

Tags: abdominal, age, amenorrhea, annex, anti, benign, bleeding, blood, body, cancer, carcinoma, care, cases, cause, cell, cells, chemotherapy, clinical, cyst, cystic, days, diagnosis, dose, drug, drugs, early, eat, ert, estrogen, examination, exploration, gene, grams, growth, gynecological, history, incidence, increased, injection, intraperitoneal, intravenous, irradiation, life, lymph, malignant, mass, metastasis, method, node, oppression, ovarian, ovary, pain, patients, pelvic, poor, prognosis, protein, radiation, radiotherapy, rate, reduce, resection, residual, screening, staging, surface, surgery, surgical, survival, symptoms, syndrome, therapy, time, toxicity, treatment, tumor, tumors, uterine, women